A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 67
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CR
Long Form : carbapenem-resistant
No. Year Title Co-occurring Abbreviation
2019 A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis. ESBL, ICU, MCDA, MDR, PPL, TOTEM, WHO
2019 A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance. ---
2019 A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired andVentilator-Associated Pneumonia: A Retrospective Cohort Study. CS, HAP, VAP
2019 Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012. CephR, CI, OR
2019 Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017). BSIs, ICUs, MRSA
2019 Carbapenem-Resistant Klebsiella Pneumoniae in Iran: a Systematic Review and Meta-Analysis. ---
2019 Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study. CRE, EMA
2019 Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey. AMR, Carba NP, IMI, MALDI-TOF
2019 Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia. AB, CV
10  2019 Genetic relatedness in carbapenem-resistant isolates from clinical specimens in Ghana using ERIC-PCR technique. ERIC, ERIC-PCR
11  2019 Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list. GNI, VR E. faecium
12  2019 Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients. GNB, HSCT
13  2019 Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines. CPS
14  2019 New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship. MbetaL, XDR
15  2019 Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacilli Pathogens from Hospitals in Ghana. MIC
16  2019 Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections. DTR, GNBSIs, non-MDR, PDR, XDR
17  2019 Trends in Klebsiella pneumoniae strains isolated from the bloodstream in a teaching hospital in southern Italy. MDR, PDR, WT, XDR
18  2019 Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from In vitro study. ATM, C/A, CRKp, MICs
19  2018 Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017. ANRESIS, ESC-R, GRE, IQR, MRSA, NH
20  2018 Antimicrobial agents active against carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates in Lebanon. MICs
21  2018 Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. AMR, BSI, CARSS, ESBL
22  2018 Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. BSIs, ESBL, MDR, VREs
23  2018 Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations. ICU
24  2018 Development and Assessment of Risk Scores for Carbapenem and Extensive beta-Lactam Resistance Among Adult Hospitalized Patients With Pseudomonas aeruginosa Infection. EBR, KPSC, ORs
25  2018 EPIDEMIOLOGY OF CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE IN INTENSIVE CARE UNITS OF MULTIPROFILE HOSPITALS IN TBILISI, GEORGIA. AST
26  2018 Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. AMR, CI
27  2018 High prevalence of hypervirulent Klebsiella pneumoniae infection in the genetic background of elderly patients in two teaching hospitals in China. ESBL, hvKp, OR
28  2018 Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance. CR-Kp
29  2018 Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis. PDR, XDR
30  2018 Iron Acquisition and Siderophore Release by Carbapenem-Resistant Sequence Type 258 Klebsiella pneumoniae. CAS, CRE, Ent, sequence type 258
31  2018 Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection. CPS, mAb, ST258
32  2018 Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand. GNB, ICUs
33  2017 blaOXA-23-like and blaTEM rather than blaOXA-51-like contributed to a high level of carbapenem resistance in Acinetobacter baumannii strains from a teaching hospital in Xi'an, China. PCR
34  2017 Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience. KP, MDR
35  2017 Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure. ---
36  2017 Cluster-distinguishing genotypic and phenotypic diversity of carbapenem-resistant Gram-negative bacteria in solid-organ transplantation patients: a comparative study. AMK, CS, GEN, PFGE
37  2017 Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department. ASP, HCWs, ICM, SOT
38  2017 In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. ESBL, PK/PD
39  2017 Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012. CI, MDR, OR
40  2017 Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. CI, CS, OR
41  2017 Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital. HPC, ICU, MDRO, REF, UHF
42  2017 Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome. BSI, PA
43  2017 Risk factors and clinical outcomes for carbapenem-resistant Gram-negative late-onset sepsis in a neonatal intensive care unit. CS, GN, LOS, NICU, TPN
44  2017 Risk Factors for Urinary Tract Infections in Renal Allograft Recipients: Experience of a Tertiary Care Center in Hyderabad, South India. CI
45  2017 The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals. ESC-R
46  2016 Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae. APACHE II
47  2016 Anatomic, Geographic, and Taxon-Specific Relative Risks of Carbapenem Resistance in the Health Care System of the U.S. Department of Defense. ---
48  2016 Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. BMD, ESBL, FDA, MDR
49  2016 Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel). AL, BSIs, GN, GP, REL
50  2016 Investigating the in vitro synergistic activities of several antibiotic combinationsagainst carbapenem-resistant Acinetobacter baumannii isolates. A. baumannii, CST, E-test, MEM, SUL, TGC
51  2016 Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature. ESBL, MICs
52  2015 Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review. MDR, MIC
53  2015 Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system. CRE
54  2015 High prevalence of carbapenem resistance among plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units. aLTU, BSI, DHA-1-ST11, pAmpC, pAmpC-Kp, pLTU
55  2015 Task force on management and prevention of Acinetobacter baumannii infections in the ICU. ESCMID
56  2015 Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BSI, CS, ICUs, KP
57  2015 Using an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 Hours. AB, KP, PA, UA
58  2014 Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. CI, OR, rep-PCR
59  2013 Antibiotic consumption and healthcare-associated infections caused by multidrug-resistant gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship. HAIs, MDR-GNB
60  2013 Antibiotic trapping by plasmid-encoded CMY-2 beta-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli. CS
61  2013 Multidrug-resistant organisms in a routine ward environment: differential propensity for environmental dissemination and implications for infection control. MDROs, MRSA, VRE
62  2013 Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients. CS, GNB, ICU
63  2012 Drugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010. DOT, MDR, PD, VAMCs
64  2011 Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China. IRAB, MBLs, MDR, RAPD
65  2010 Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. VAP
66  2007 Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. MBL, PFGE
67  2000 Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. CI, ICUs, RR